Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 16, 2025 08:00 ET | Source: Jyong Biotech Ltd.

Jyong Biotech Announces Completion of Patient Enrollment of over 700 subjects in Phase II Clinical Trial of MCS‑8 for Prostate Cancer Prevention

New Taipei City, Taiwan, Sept. 16, 2025 (GLOBE NEWSWIRE) -- Jyong Biotech Ltd. (Nasdaq: MENS) (the “Company”, “Jyong Biotech”), a science-driven biotechnology company based in Taiwan committed to...
August 19, 2025 08:54 ET | Source: Sixty Degrees Pharmaceuticals

60 Degrees Pharmaceuticals Selects Icahn School of Medicine at Mount Sinai as Central Clinical Trial Site for Phase II Study to Evaluate Tafenoquine for Chronic Babesiosis

60 Degrees Pharma selects Mount Sinai as central site for Phase II tafenoquine trial in chronic babesiosis; enrollment starts Q4 2025, data 2026.
May 19, 2025 08:00 ET | Source: Alzamend Neuro, Inc.

Alzamend Neuro Enrolls First Patient in its Phase II Clinical Trial of AL001 “Lithium in Brain” Study Taking Place at Massachusetts General Hospital

Alzamend Neuro Enrolls First Patient in its Phase II Clinical Trial of AL001 “Lithium in Brain” Study Taking Place at Massachusetts General Hospital
May 07, 2025 08:00 ET | Source: Alzamend Neuro, Inc.

Alzamend Neuro Partners with QMENTA, to Advance AI-Powered Imaging for its Phase II Clinical Trial of AL001 Study to Take Place at Massachusetts General Hospital

Alzamend Neuro Partners with QMENTA, to Advance AI-Powered Imaging for Its Phase II Clinical Trial of AL001 Study to Take Place at Mass. General Hospital
April 17, 2025 05:54 ET | Source: Research and Markets

Clinical Trial Services Research Report 2025: Oncology, Neurology, Dermatology, CVD, Laboratory, Monitoring, Recruitment, PV, Data Management - Global Forecast to 2030

Dublin, April 17, 2025 (GLOBE NEWSWIRE) -- "Clinical Trial Services Market by Type (Laboratory, Monitoring, Recruitment, PV, Data Management), Phase (I, II, III), Therapy (Oncology, Neurology,...
February 28, 2025 04:06 ET | Source: Research and Markets

Saudi Arabia Targets the $200 Million Clinical Trials Market with Over 400 Studies Underway

Dublin, Feb. 28, 2025 (GLOBE NEWSWIRE) -- The "Saudi Arabia Clinical Trials Market, Ongoing Clinical Trials by Company, Indication, Phase & Regulations Insight 2025" report has been added to ...
January 06, 2025 10:13 ET | Source: Research and Markets

AI in Clinical Trials Market Research 2024-2030 with In-depth Assessment of Market Shares, Growth Strategies, and Service Offerings of Leading Players

Dublin, Jan. 06, 2025 (GLOBE NEWSWIRE) -- The "AI in Clinical Trials Market by Function, Phase, Indication, Tool, End-User & Region - Global Forecast to 2030" report has been added to ...
June 05, 2024 03:41 ET | Source: Research and Markets

$43+ Billion Cell and Gene Therapy Clinical Trials Market Forecast, 2024-2034, by Therapy Type, Phase, Indication, and Region

Dublin, June 05, 2024 (GLOBE NEWSWIRE) -- The "Global Cell and Gene Therapy Clinical Trials Market Analysis & Forecast to 2024-2034" report has been added to ResearchAndMarkets.com's...
February 09, 2024 07:40 ET | Source: Research and Markets

Global Clinical Trials Market to Surge to $73.2 Billion by 2028, Driven by Demand for Specialized Testing Services and Outsourcing to CROs

Dublin, Feb. 09, 2024 (GLOBE NEWSWIRE) -- The "Global Clinical Trials Market by Phase (Phase I, II, III), Service Type (Laboratory, Analytical Testing, Patient Recruitment, Protocol Designing),...
November 06, 2023 06:23 ET | Source: Research and Markets

World Edema Clinical Trials (Phase I, Phase II, Phase III, Phase IV) Market Size, Share & Trends Analysis Report 2023-2030

Dublin, Nov. 06, 2023 (GLOBE NEWSWIRE) -- The "Edema Clinical Trials Market Size, Share & Trends Analysis Report By Phase (Phase I, Phase II, Phase III, Phase IV), By Participant (Pediatrics,...